Clinical Trials
4 trialsNCT00064025 2016-04-11
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
GOG Foundation
Phase 2 Completed
NCT00003179 2013-06-10
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00033358 2013-05-03
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002920 2012-10-31
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed